Profile data is unavailable for this security.
About the company
Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
- Revenue in NOK (TTM)16.10m
- Net income in NOK-51.80m
- Incorporated2006
- Employees32.00
- LocationLifecare ASAYtrebygdsvegen 215BERGEN 5258NorwayNOR
- Websitehttps://lifecare.no/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kancera AB | 0.00 | -53.12m | 131.01m | 5.00 | -- | 1.57 | -- | -- | -0.5955 | -0.5955 | 0.00 | 0.6849 | 0.00 | -- | -- | 0.00 | -56.73 | -54.82 | -66.40 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
| Lumito AB (publ) | 17.02k | -31.90m | 131.93m | 13.00 | -- | 1.29 | -- | 7,313.17 | -0.1472 | -0.1472 | 0.00008 | 0.4133 | 0.0001 | -- | 2.43 | 1,133.33 | -26.73 | -20.77 | -30.85 | -22.38 | 42,235.47 | -- | -187,433.80 | -- | 1.10 | -14.60 | 0.1715 | -- | -- | -- | 4.56 | -- | -- | -- |
| Biovica International AB | 7.26m | -115.56m | 151.65m | 27.00 | -- | 1.69 | -- | 20.87 | -1.73 | -1.73 | 0.1055 | 1.06 | 0.0584 | 17.30 | 4.76 | 226,593.80 | -92.98 | -51.94 | -110.37 | -58.18 | -394.72 | -576.01 | -1,592.15 | -2,217.41 | 3.47 | -- | 0.0721 | -- | 115.49 | 19.39 | -12.97 | -- | -54.31 | -- |
| Acousort AB | 3.44m | -19.32m | 170.42m | -- | -- | 11.13 | -- | 49.51 | -1.33 | -1.33 | 0.2379 | 1.02 | 0.1461 | 4.08 | 1.96 | -- | -81.99 | -48.62 | -137.70 | -69.77 | -159.41 | -68.05 | -561.21 | -299.58 | 1.91 | -- | 0.00 | -- | 11.51 | 38.81 | -24.01 | -- | -- | -- |
| Biosergen AB | 0.00 | -23.45m | 177.25m | 2.00 | -- | 7.49 | -- | -- | -0.2273 | -0.2273 | 0.00 | 0.0822 | 0.00 | -- | -- | 0.00 | -179.89 | -- | -244.13 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 32.25 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -54.84m | 186.07m | 12.00 | -- | 10.49 | -- | -- | -1.66 | -1.66 | 0.00 | 0.5435 | 0.00 | -- | -- | -- | -130.29 | -40.21 | -170.98 | -45.67 | -- | -- | -- | -- | -- | -- | 0.0502 | -- | -- | -- | -20.52 | -- | -- | -- |
| ViroGates A/S | 6.53m | -20.58m | 192.48m | 10.00 | -- | 15.00 | -- | 30.40 | -5.64 | -5.64 | 0.8338 | 1.10 | 0.2935 | 0.4667 | 3.62 | 419,900.00 | -92.50 | -46.58 | -105.88 | -52.09 | 57.25 | 77.91 | -315.15 | -238.01 | 6.13 | -19.84 | 0.4278 | -- | -45.01 | 10.98 | -25.40 | -- | -- | -- |
| Intervacc AB | 9.30m | -77.41m | 192.56m | 15.00 | -- | 1.07 | -- | 20.72 | -1.02 | -1.02 | 0.1226 | 2.38 | 0.0386 | 5.09 | 1.59 | 619,066.70 | -32.15 | -17.62 | -35.27 | -18.77 | -432.03 | -243.59 | -832.82 | -626.90 | 2.26 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
| Lifecare ASA | 15.07m | -59.84m | 199.75m | 32.00 | -- | 0.1789 | -- | 13.83 | -16.49 | -16.49 | 1.51 | 73.51 | 0.1698 | -- | 1.56 | 471,007.80 | -67.36 | -40.00 | -86.96 | -45.26 | -- | -- | -396.68 | -175.53 | -- | -- | 0.1102 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
| Xintela AB | 381.38k | -40.87m | 200.40m | -- | -- | -- | -- | 525.47 | -0.0817 | -0.0817 | 0.0008 | -0.0319 | 0.0306 | -- | 0.0493 | -- | -327.65 | -181.06 | -- | -391.61 | 100.00 | -- | -10,717.06 | -235,894.00 | -- | -203.91 | -- | -- | -- | -45.54 | 18.32 | -- | -61.47 | -- |
| SenzaGen AB | -100.10bn | -100.10bn | 206.73m | 33.00 | -- | 2.31 | -- | -- | -- | -- | -- | 3.03 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 3.18 | -- | 0.0225 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
| Abliva AB | 137.14k | -102.23m | 213.63m | 6.00 | -- | 2.12 | -- | 1,588.35 | -0.0928 | -0.0928 | 0.0001 | 0.0638 | 0.0013 | -- | 0.0062 | 22,833.33 | -93.81 | -74.59 | -103.87 | -86.98 | -35,826.28 | -- | -74,542.34 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -87.29m | 248.60m | 6.00 | -- | 3.85 | -- | -- | -8.16 | -8.16 | 0.00 | 5.25 | 0.00 | -- | -- | -- | -96.71 | -69.56 | -117.53 | -78.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.4289 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -52.50m | 255.02m | 4.00 | -- | 9.99 | -- | -- | -0.1734 | -0.1734 | 0.00 | 0.0471 | 0.00 | -- | -- | 0.00 | -235.29 | -125.42 | -407.84 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
| Ascelia Pharma AB | 0.00 | -62.36m | 256.31m | 13.00 | -- | 2.36 | -- | -- | -1.12 | -1.12 | 0.00 | 1.11 | 0.00 | -- | -- | 0.00 | -46.53 | -- | -56.96 | -- | -- | -- | -- | -- | -- | -10.21 | 0.1983 | -- | -- | -- | 16.72 | -- | -- | -- |
Data as of Nov 21 2024. Currency figures normalised to Lifecare ASA's reporting currency: Norwegian Krone NOK
5.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management AB (Norway)as of 12 Feb 2024 | 796.57k | 5.03% |
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
